Key result
In a canine model, sotalol combined with quinidine reduced the incidence of torsades de pointes during the first hour compared to sotalol alone.
Why the study?
Does the combination of sotalol and quinidine increase proarrhythmic events compared to sotalol alone in a canine model of acquired long QT syndrome?
Does the combination of sotalol and quinidine increase proarrhythmic events compared to sotalol alone in a canine model of acquired long QT syndrome?
In a canine model of long QT syndrome, combining sotalol with quinidine was not more arrhythmogenic than sotalol alone, challenging the theoretical additive proarrhythmic effect of Class IA and III drugs.
Answers are grounded in this paper and cite their sources.
Challenges expected additive proarrhythmia of Class IA+III agents in this model; leaves open human relevance and need for further study.
INTRODUCTION: Clinical treatment with a combination of Class IA and III antiarrhythmic drugs is not recommended, as they both favor bradycardia-dependent proarrhythmic events such as torsades de pointes (TdP). However, this theoretical additive effect on ventricular repolarization has never been demonstrated and could be questioned as other Class I drugs, such as mexiletine, a Class IB drug, limit the number of sotalol-induced TdP in dogs with AV block, suggesting the possibility of an antagonistic action of Class I properties against Class III effects. METHODS AND RESULTS: We compared the electrophysiologic and proarrhythmic effects of sotalol (Class III) alone and combined with quinidine (Class IA) in a canine model of acquired long QT syndrome. Seven hypokalemic (K+: 3 +/- 0.1 mEq/L) dogs with chronic AV block had a demand pacemaker implanted and set at a rate of 25 beats/min. They were submitted to two (sotalol-alone and sotalol-plus-quinidine) experiments 48 hours apart using a randomized cross-over protocol. They were pretreated with quinidine (10 mg/kg + 1.8 mg/kg per hour) or saline infused throughout the experiment, and given sotalol (4.5 mg/kg + 1.5 mg/kg per hour) for 2 hours, 30 minutes after the beginning of the pretreatment infusion during both experiments. Ventricular and atrial cycle lengths were similarly increased by sotalol after quinidine or saline. The sotalol-induced prolongation of the QT interval was significantly shorter in quinidine-pretreated dogs (24 +/- 7 msec after quinidine vs 40 +/- 8 msec after saline). Fewer dogs developed TdP: significantly during the first hour of infusion (1/7 sotalol-plus-quinidine vs 6/7 sotalol-alone dogs, P < 0.05) but nonsignificantly during the second hour (3/7 vs 6/7). CONCLUSION: In this model, the sotalol-plus-quinidine combination is at least no more arrhythmogenic than either of the drugs given alone.
No takes yet. Share an insight, caveat, or question.
Chézalviel-Guilbert et al. (1998) studied Acquired long QT syndrome (n=7). Sotalol plus quinidine vs. Sotalol alone (with saline) was evaluated on Development of torsades de pointes (TdP) during the first hour of infusion (p=< 0.05). In a canine model, sotalol combined with quinidine reduced the incidence of torsades de pointes during the first hour compared to sotalol alone.
Synapse has enriched 10 related papers. Consider them for comparative context: